T2 Biosystems Inc (TTOO)
0.50
+0.07
(+17.43%)
USD |
NASDAQ |
Nov 22, 14:40
T2 Biosystems Shareholders Equity (Quarterly): -11.71M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.71M |
| June 30, 2024 | -5.898M |
| March 31, 2024 | -37.77M |
| December 31, 2023 | -28.04M |
| September 30, 2023 | -19.24M |
| June 30, 2023 | -36.42M |
| March 31, 2023 | -49.89M |
| December 31, 2022 | -39.66M |
| September 30, 2022 | -31.67M |
| June 30, 2022 | -37.52M |
| March 31, 2022 | -25.65M |
| December 31, 2021 | -12.90M |
| September 30, 2021 | -2.463M |
| June 30, 2021 | 9.009M |
| March 31, 2021 | -0.566M |
| December 31, 2020 | 8.726M |
| September 30, 2020 | 17.57M |
| June 30, 2020 | -4.388M |
| March 31, 2020 | -7.697M |
| December 31, 2019 | -34.00M |
| September 30, 2019 | -25.91M |
| June 30, 2019 | -15.62M |
| Date | Value |
|---|---|
| March 31, 2019 | -1.58M |
| December 31, 2018 | 11.39M |
| September 30, 2018 | 23.76M |
| June 30, 2018 | 31.98M |
| March 31, 2018 | -10.09M |
| December 31, 2017 | 1.34M |
| September 30, 2017 | 18.13M |
| June 30, 2017 | 12.32M |
| March 31, 2017 | 26.03M |
| December 31, 2016 | 39.34M |
| September 30, 2016 | 50.58M |
| June 30, 2016 | 22.66M |
| March 31, 2016 | 35.09M |
| December 31, 2015 | 46.94M |
| September 30, 2015 | 23.81M |
| June 30, 2015 | 34.05M |
| March 31, 2015 | 43.48M |
| December 31, 2014 | 53.00M |
| September 30, 2014 | 61.43M |
| June 30, 2014 | -106.98M |
| March 31, 2014 | 17.70M |
| December 31, 2013 | -89.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-49.89M
Minimum
Mar 2023
17.57M
Maximum
Sep 2020
-17.51M
Average
-16.07M
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| Cardinal Health Inc | -3.277B |
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.08M |
| Total Liabilities (Quarterly) | 29.79M |
| Debt to Equity Ratio | -1.018 |
| Current Ratio | 0.4005 |
| Net Debt Paydown Yield | 20.92% |